Biogen Idec Inc. (NASDAQ:BIIB) the Cambridge biotechnology firm that already makes the multiple sclerosis drugs Avonex, Tysabri, and Tecfidera, said Friday that its new MS drug is potentially closer to market approval in Europe. Biogen Idec Inc. (NASDAQ:BIIB) net profit margin is 25.00% and weekly performance is 2.88%. On last trading day company shares ended up $299.71. Analysts mean target price for the company is $345.53. Biogen Idec Inc. (NASDAQ:BIIB) distance from 50-day simple moving average (SMA50) is -0.21%.
China’s leading online direct sales company JD.com, Inc. (ADR) (NASDAQ:JD) Thursday successfully listed its shares on NASDAQ and recorded the largest initial public offering (IPO) by a Chinese company in the United States. JD.Com Inc. (ADR) (NASDAQ:JD) shares fell -3.83% in last trading session and ended the day on $20.10.
Whole Foods Market Inc. (NASDAQ:WFM) is recalling Thai Soba Noodle Salad sold in all stores in five states due to an undeclared soy allergen. The product has a Use by Date of: 5/25/14. Whole Foods Market, Inc. (NASDAQ:WFM) shares moved up 0.75% in last trading session and was closed at $37.78, while trading in range of $37.27 – $37.90. Whole Foods Market, Inc. (NASDAQ:WFM) year to date (YTD) performance is -34.38%.
A significant shareholder in the global online travel company Orbitz Worldwide, Inc. (NYSE:OWW) has plans to reduce its stake in the company. Orbitz will neither receive any proceeds from the sale nor have its shares diluted. As such, the transaction has no impact on the share value of the current shareholders. Orbitz Worldwide, Inc. (NYSE:OWW) ended the last trading day at $7.24. Company weekly volatility is calculated as 6.11% and price to cash ratio as 3.17.Orbitz Worldwide, Inc. (NYSE:OWW) showed a negative weekly performance of -3.47%.